Liquid biopsy in hematological malignancies: current and future applicationsDonatella Talotta, Riccardo Moia, Mohammad Almasri et al.|Frontiers in Oncology|2023Cited by 26
<i>XPO1</i> mutations identify early‐stage <scp>CLL</scp> characterized by shorter time to first treatment and enhanced <scp>BCR</scp> signallingRiccardo Moia, Gianluca Gaïdano, Wael Al Essa et al.|British Journal of Haematology|2023Cited by 7
<i>TP53</i>, <i>CD36</i> Mutations and <i>CDKN2A</i> Loss Predict Poor Outcome in Mantle Cell Lymphoma: Molecular Analysis of the FIL V-Rbac Phase 2 TrialRiccardo Moia, Carlo Visco, Maria Elena Carazzolo et al.|Blood|2024Cited by 3
Integration of [18f]FDG-PET Radiomics with Liquid Biopsy Improves Outcome Prediction in Newly Diagnosed DLBCL PatientsRiccardo Dondolin, Riccardo Moia, Federico Garrou et al.|Blood|2024Cited by 2
MOLECULAR CLUSTERING ON CTDNA IMPROVES THE PROGNOSTIC STRATIFICATION OF DLBCL PATIENTS COMPARED TO CTDNA LEVELSRiccardo Moia, Gianluca Gaïdano, Donatella Talotta et al.|Hematological Oncology|2023Cited by 1